130 related articles for article (PubMed ID: 16101185)
1. Expression of vascular endothelial growth factor and its receptor, KDR/Flk-1, in soft tissue sarcomas.
Pakos EE; Goussia AC; Tsekeris PG; Papachristou DJ; Stefanou D; Agnantis NJ
Anticancer Res; 2005; 25(5):3591-6. PubMed ID: 16101185
[TBL] [Abstract][Full Text] [Related]
2. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
[TBL] [Abstract][Full Text] [Related]
3. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
Fine BA; Valente PT; Feinstein GI; Dey T
Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of tissue vascular endothelial growth factor and foetal liver kinase-1 receptor in seasonal allergic rhinitis and relevance to asthma component.
Yuksel H; Kose C; Yilmaz O; Ozbilgin K; Degirmenci PB; Pinar E; Kirmaz C
Clin Exp Allergy; 2007 Aug; 37(8):1183-8. PubMed ID: 17651148
[TBL] [Abstract][Full Text] [Related]
5. Microvessel density does not predict outcome in high grade soft tissue sarcoma.
West CC; Brown NJ; Mangham DC; Grimer RJ; Reed MW
Eur J Surg Oncol; 2005 Dec; 31(10):1198-205. PubMed ID: 15993027
[TBL] [Abstract][Full Text] [Related]
6. Concentration of vascular endothelial growth factor in the tumour tissue as a prognostic factor of soft tissue sarcomas.
Yudoh K; Kanamori M; Ohmori K; Yasuda T; Aoki M; Kimura T
Br J Cancer; 2001 Jun; 84(12):1610-5. PubMed ID: 11401313
[TBL] [Abstract][Full Text] [Related]
7. The angiogenic pathway "vascular endothelial growth factor/flk-1(KDR)-receptor" in rheumatoid arthritis and osteoarthritis.
Giatromanolaki A; Sivridis E; Athanassou N; Zois E; Thorpe PE; Brekken RA; Gatter KC; Harris AL; Koukourakis IM; Koukourakis MI
J Pathol; 2001 May; 194(1):101-8. PubMed ID: 11329148
[TBL] [Abstract][Full Text] [Related]
8. The role of tumor vascularisation in benign and malignant cardiovascular neoplasms: a comparison of cardiac myxoma and sarcomas of the pulmonary artery.
Gaumann A; Strubel G; Bode-Lesniewska B; Schmidtmann I; Kriegsmann J; Kirkpatrick CJ
Oncol Rep; 2008 Aug; 20(2):309-18. PubMed ID: 18636191
[TBL] [Abstract][Full Text] [Related]
9. [Expression of vascular endothelial growth factor and its receptor Flk-1/KDR in benign and malignant breast neoplasms].
Li YJ; Wen G; Wang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):70-1, 74. PubMed ID: 19218116
[TBL] [Abstract][Full Text] [Related]
10. Analysis of vascular endothelial growth factor (VEGF) and a receptor subtype (KDR/flk-1) in the liver of rats exposed to riddelliine: a potential role in the development of hemangiosarcoma.
Moyer C; Allen D; Basabe A; Maronpot RR; Nyska A
Exp Toxicol Pathol; 2004 Jul; 55(6):455-65. PubMed ID: 15384251
[TBL] [Abstract][Full Text] [Related]
11. Expression of vascular endothelial growth factor and receptor flk-1 in colon cancer liver metastases.
Cheng J; Slavin RE; Gallagher JA; Zhu G; Biehl TR; Swanstrom LL; Hansen PD
J Hepatobiliary Pancreat Surg; 2004; 11(3):164-70. PubMed ID: 15235888
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of angiogenesis in the tumorigenesis and progression of breast cancer].
Li YJ; Deng YJ; Wen G; Zhang XL
Zhonghua Wai Ke Za Zhi; 2009 Apr; 47(7):519-22. PubMed ID: 19595210
[TBL] [Abstract][Full Text] [Related]
13. Study of microvessel density and the expression of the angiogenic factors VEGF, bFGF and the receptors Flt-1 and FLK-1 in benign, premalignant and malignant prostate tissues.
Pallares J; Rojo F; Iriarte J; Morote J; Armadans LI; de Torres I
Histol Histopathol; 2006 Aug; 21(8):857-65. PubMed ID: 16691538
[TBL] [Abstract][Full Text] [Related]
14. The angiogenic "vascular endothelial growth factor/flk-1(KDR) receptor" pathway in patients with endometrial carcinoma: prognostic and therapeutic implications.
Giatromanolaki A; Sivridis E; Brekken R; Thorpe PE; Anastasiadis P; Gatter KC; Harris AL; Koukourakis MI;
Cancer; 2001 Nov; 92(10):2569-77. PubMed ID: 11745191
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas.
Niveiro M; Aranda FI; Peiró G; Alenda C; Picó A
Hum Pathol; 2005 Oct; 36(10):1090-5. PubMed ID: 16226108
[TBL] [Abstract][Full Text] [Related]
16. Non-endothelial KDR/flk-1 expression is associated with increased survival of patients with urothelial bladder carcinomas.
Gakiopoulou-Givalou H; Nakopoulou L; Panayotopoulou EG; Zervas A; Mavrommatis J; Giannopoulos A
Histopathology; 2003 Sep; 43(3):272-9. PubMed ID: 12940780
[TBL] [Abstract][Full Text] [Related]
17. Prognostic importance of vascular endothelial growth factor and its receptors in the uterine sarcoma.
Arita S; Kikkawa F; Kajiyama H; Shibata K; Kawai M; Mizuno K; Nagasaka T; Ino K; Nomura S
Int J Gynecol Cancer; 2005; 15(2):329-36. PubMed ID: 15823121
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor in thoracic sarcomas.
Iyoda A; Hiroshima K; Baba M; Fujisawa T; Yusa T; Ohwada H
Ann Thorac Surg; 2001 May; 71(5):1635-9. PubMed ID: 11383813
[TBL] [Abstract][Full Text] [Related]
19. Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease.
Kranenburg AR; de Boer WI; Alagappan VK; Sterk PJ; Sharma HS
Thorax; 2005 Feb; 60(2):106-13. PubMed ID: 15681497
[TBL] [Abstract][Full Text] [Related]
20. Expression of VEGF and its receptors and angiogenesis in bone and soft tissue tumors.
Hara H; Akisue T; Fujimoto T; Imabori M; Kawamoto T; Kuroda R; Fujioka H; Yamamoto T; Doita M; Kurosaka M
Anticancer Res; 2006; 26(6B):4307-11. PubMed ID: 17201149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
